Title: Comprehensive Guide: Dosage, Effects, Mechanism, and Further Information on Camzyos
In August 2025, the brand-name prescription medication Camzyos (mavacamten) remains without a lower-cost generic version available [1]. Approved primarily for adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM), Camzyos is a crucial treatment option for those suffering from this heart condition.
Due to potential serious side effects, such as the risk of heart failure, Camzyos is available only through a special Risk Evaluation and Mitigation Strategy (REMS) program [1][5]. The existing formulations, such as the "Mava 5 mg" capsule, refer to the branded Camzyos product supplied by Bristol-Myers Squibb and are not generics, despite sometimes being referred to by their generic chemical name, mavacamten [3].
To ensure patient safety, it is essential to take Camzyos according to the instructions given by your doctor. Camzyos oral capsules should be stored at a temperature of 68°F to 77°F (20°C to 25°C) and should be swallowed whole [1]. It is not recommended to crush, split, or chew the capsules.
One important precaution to consider when taking Camzyos is the potential interaction with grapefruit and grapefruit juice. The drug carries a boxed warning about the risk of heart failure when eating grapefruit or drinking grapefruit juice [1]. Therefore, it is advised to avoid consuming these products during Camzyos treatment.
Camzyos may also interact with certain hormonal birth control pills, making them less effective [1]. If you are planning to become pregnant, it is crucial to use birth control while taking Camzyos and for at least 4 months after your last dose. If you are breastfeeding or planning to do so, it is essential to discuss the risks and benefits of taking Camzyos with your doctor.
It is also important to store Camzyos in a safe place, away from areas where it could get damp or wet, such as bathrooms. This helps prevent others, including children and pets, from taking the drug by accident.
In addition to following these precautions, it is recommended to check with your doctor or pharmacist before using any herbs or supplements while taking Camzyos [1]. It is also crucial to dispose of any unused medication that has gone past the expiration date safely and to dispose of any leftover medication when no longer needed.
In summary, while there is currently no lower-cost generic version of Camzyos available, the drug remains a vital treatment option for adults with symptomatic obstructive hypertrophic cardiomyopathy. By following the safety precautions and guidelines provided by your doctor and pharmacist, you can ensure the safe and effective use of Camzyos in managing this heart condition.
[1] Drugs.com. (2025). Camzyos (mavacamten) [Prescribing Information]. Retrieved from https://www.drugs.com/pro/camzyos.html [2] FDA. (2022). FDA approves Camzyos (mavacamten) for obstructive hypertrophic cardiomyopathy. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-camzyos-mavacamten-obstructive-hypertrophic-cardiomyopathy [3] Bristol-Myers Squibb. (2022). Camzyos (mavacamten) [Product Information]. Retrieved from https://www.bms.com/research/pipeline/mavacamten.html [4] Express Scripts. (2025). Camzyos (mavacamten) [Formulary]. Retrieved from https://www.express-scripts.com/formulary/drug/camzyos [5] REMS Program for Camzyos. (2022). Retrieved from https://www.fda.gov/drugs/resources-information-approved-drugs/camzyos-mavacamten-obstructive-hypertrophic-cardiomyopathy-rem-program-information-patients-and-caregivers
Deciders of medical-conditions should be aware that Camzyos, though crucial for the health-and-wellness of individuals with symptomatic obstructive hypertrophic cardiomyopathy, requires meticulous handling and precautions. For instance, it should be stored at specified temperatures and avoided with certain foods such as grapefruit. Furthermore, potential interactions exist with certain medical-conditions and medications, as with hormonal birth control pills, necessitating careful consideration and communication between patients and medical professionals.
